ChemAxon, a leader in providing chemistry software solutions and consulting services for life science research, announces the opening of its new US East Coast headquarters in Cambridge, Mass. Located at the heart of Boston’s biotechnology hub, these new offices will concentrate technical, scientific, and consultancy support as well as business development operations. ChemAxon is also recruiting to meet strong growth in demand for its chemistry software in this region.
ChemAxon sets the standard in chemically-intelligent software for new product R&D. With a client list that includes all of the top 15 global pharmas, the company continues to experience significant growth year on year.
“Going forward our strategy is about developing the strong collaborative relationships we have with customers and business partners,” commented Alex Drijver, CEO of ChemAxon. “Locating in this key US pharma-biotech hub helps us ensure our technology evolves with customer requirements, and they gain more business value from their chemistry.”
Date: September 24, 2012
Source: ChemAxon
Filed Under: Drug Discovery
